Same Indication

Nivolumab vs Simvastatin

## Nivolumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Simvastatin**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Simvastatin**: Prodrug converted to active form that inhibits HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Simvastatin — 2 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Simvastatin — C25H38O5.

**Molecular Weight**: Nivolumab — N/A; Simvastatin — 418.5700 g/mol.

**Type**: Nivolumab — Antibody; Simvastatin — Small molecule.